Resolute Science

About:

Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat.

Website: https://resolutescience.com/

Top Investors: National Cancer Institute

Description:

Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat. Founded with the goal of curing solid tumors, Resolute uses the technology platform of MAC-TACs (Macrophage Targeted Conjugates) to develop a wide range of biomarker-driven, first-in-class, synthetic molecules that are potentially safer and more effective than current standard of care for pan-cancer patients.